新股消息 | 吉因加递表港交所

Core Viewpoint - GeneTech (Shaoxing) Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, indicating its position as a leading precision medicine company in China that integrates AI capabilities into the biomarker value chain [1] Company Overview - GeneTech utilizes a self-developed multi-omics platform, combining foundational large models and intelligent AI to create a comprehensive capability from the discovery and validation of multi-omics biomarkers and targets to product development and commercialization [1] Solutions Offered - The company provides three main solutions targeting hospitals, pharmaceutical and biotechnology companies, and medical research institutions: 1. Precision Diagnosis 2. Drug Development Empowerment 3. Clinical Research and Translation [1]